Scholarlink

<p>Individual health services (IGeL) require direct physician–patient interaction, including personal information, informed consent, and transparent cost clarification. These structural prerequisites are typically not met in dermatopathology, where indication and patient counselling are performed by the referring physician, while diagnostic responsibility and billing consequences rest with the dermatopathologist. This constellation results in unclear responsibilities and relevant legal and organizational risks. This article analyzes the structural limitations of the IGeL framework in dermatopathology and discusses typical conflict scenarios from both a&#xa0;legal and diagnostic perspective. Key aspects include billing risks, liability issues, challenges related to stepwise diagnostics, and the distinction between IGeL services, self-pay services, and regular private insurance billing. In addition, defensive medical practices and communication deficits are addressed as factors that may affect diagnostic quality and legal certainty. Dermatopathology is used as an exemplary field, as the underlying mechanisms and conflicts are transferable to other clinically active specialties, particularly clinical dermatology. The aim of this article is to highlight structural problem areas and to stimulate a&#xa0;fact-based professional discussion on responsibility, billing pathways, and medical necessity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

IGeL in der Dermatopathologie – strukturelle Grenzen und rechtliche Risiken

  • 期刊论文

  • 发表日期：

    2026年6月2日

查看全文
  • Cornelia Sigrid Lissi Müller,
  • Torsten Hansen,
  • Claus Renzelmann

摘要

Individual health services (IGeL) require direct physician–patient interaction, including personal information, informed consent, and transparent cost clarification. These structural prerequisites are typically not met in dermatopathology, where indication and patient counselling are performed by the referring physician, while diagnostic responsibility and billing consequences rest with the dermatopathologist. This constellation results in unclear responsibilities and relevant legal and organizational risks. This article analyzes the structural limitations of the IGeL framework in dermatopathology and discusses typical conflict scenarios from both a legal and diagnostic perspective. Key aspects include billing risks, liability issues, challenges related to stepwise diagnostics, and the distinction between IGeL services, self-pay services, and regular private insurance billing. In addition, defensive medical practices and communication deficits are addressed as factors that may affect diagnostic quality and legal certainty. Dermatopathology is used as an exemplary field, as the underlying mechanisms and conflicts are transferable to other clinically active specialties, particularly clinical dermatology. The aim of this article is to highlight structural problem areas and to stimulate a fact-based professional discussion on responsibility, billing pathways, and medical necessity.